Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Norway postpones decision on AstraZeneca vaccine

Stock MarketsApr 15, 2021 16:00
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Vials labelled "AstraZeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo

OSLO (Reuters) - Norway will take more time to assess whether to resume the use of the AstraZeneca (NASDAQ:AZN) vaccine against COVID-19 or stop it altogether, health minister Bent Hoeie said on Thursday.

Norway's Institute of Public Health recommended ending the use of the AstraZeneca vaccine, in line with a Danish decision announced on Wednesday, but the government needs more information before making a final call, the minister said.

Norway on March 11 suspended the rollout of the vaccine after a small number of younger inoculated people were hospitalised for a combination of blood clots, bleeding and a low count of platelets, some of whom later died.

"The government believes that we do not have a good enough basis for drawing a final conclusion that the AstraZeneca vaccine should be removed from the Norwegian vaccination program at this point," Hoeie told a news conference.

The government will appoint a public commission to broaden the evaluation and include additional information from other countries. The commission will deliver a report by May 10, Hoeie said.

The evaluation will also concern whether to use the COVID vaccine made by Johnson & Johnson (NYSE:JNJ), also referred to as Janssen.

"If we say a final 'no' to the AstraZeneca vaccine, this could also impact our ability to consider using the Janssen vaccine, which is built on the same technology," Hoeie said.

"We have to be open to waiting for the international knowledge, and we must be open for the fact that this can lead to these vaccines being used," he added.

Norway was one of over a dozen European countries to have suspended the rollout of the vaccine, although most have since resumed its use on the advice of the European Medicines Agency, with many limiting its use to older age groups.

Denmark on Wednesday decided to drop the AstraZeneca shot however.

The suspension in Norway came after five people, all healthcare workers aged between 32 and 54 years old, were hospitalised for a combination of blood clots, bleeding and a low count of platelets that occurred seven to ten days after receiving the AstraZeneca vaccine. Three of them later died.

Norwegian researchers published their findings on April 9 in the New England Journal of Medicine (https:// in which they proposed that the cases were induced by the AstraZeneca shot.

Norway's continued suspension was partly made possible by Norway experiencing lower levels of infections than elsewhere in Europe, FHI has said.

"I respect the fact that other nations judge this differently," said Hoeie.

 

Norway postpones decision on AstraZeneca vaccine
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email